State Ledger
Company profile

Valion Bio, Inc. CIK 1787740

Ticker
VBIO (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Antonio, TX 78205
Fiscal year end
2025 (FY)
Market Data
Close
$1.54
Change
-$0.15
Change %
-8.63%
Volume
1,471

VBIO · trading date Oct 13, 2026 · previous close $1.68 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$8.88M
Total assets
$31.61M
Total liabilities
$7.44M
Stockholders' equity
$16.80M
Cash & equivalents
$12.65M
Operating income
-$7.90M
Operating cash flow
-$7.00M
Capital expenditures
$38.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$7.04M
Free cash flow margin
—
Liabilities / assets
23.5%
Equity / assets
53.1%
CapEx / revenue
—
Operating cash flow / net income
0.79×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$8.88M $31.61M $7.44M $16.80M
2024 $780.0K -$5.66M $2.81M $272.0K $2.54M
2023 $1.18M -$8.24M $5.16M $1.58M $3.58M
2022 $1.84M -$10.10M $5.88M $2.25M $3.63M
2021 $1.26M -$8.49M $15.04M $1.76M $13.27M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 3
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Antonio, TX 78205
1305 E. HOUSTON STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies